KIWI I am sure that you can answer that question and tell us all. Looking forward to your valued feedback. But do you really care what path they will follow? Unless your planning to become a shareholder?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025